Daiichi Sankyo
DSNKY18.2303.11% ( +0.550 )
Daiichi Sankyo (DSNKY)
Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally. The company offers Enhertu...
- Open
- 17.338
- High
- 18.240
- Low
- 17.338
- Prev. Close
- 17.680
- Volume
- 265.08K
- Turnover
- 4.76M
- Avg Price
- 17.957
- Bid/Ask Ratio
- --
- Amplitude
- 5.10%
- 52wk High
- 27.500
- Volume Ratio
- 0.82
- Turnover Ratio
- 0.02%
Daiichi Sankyo Analyst Rating
View MoreForecast & Rating
Jul 23, 2026Price forecast
$22.9525.89%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 4 hours ago
Daiichi Sankyo, AstraZeneca Datroway wins EU approval for first-line metastatic TNBC in non-immunotherapy patients
- PUBT · 2 hours ago
Daiichi Sankyo Q1 FY26 operating profit falls 12% to JPY 85.1 billion; revenue rises 21.1% to JPY 574.7 billion
- Quartr · 6 hours ago
Daiichi Sankyo Company: Oncology-driven revenue growth and FX gains lifted results, but profit fell on higher costs
- StockTitan · 12 hours ago
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy | AZN Stock News
- Simplywall · Jul 27 at 10:13 AM
Toyota Stock, SoftBank And Daiichi Sankyo Offer Reliable Japan Dividend Income
- Market Beat · Jul 24 at 06:00 PM
Daiichi Sankyo Co., Ltd. - Sponsored ADR (OTCMKTS:DSNKY) Short Interest Up 1,183.6% in July
